Polaryx Therapeutics PLYX Growth Metrics (2025-2026)

NASDAQ PLYX
$2.02 -0.06 (-2.88%)
As of: Sep 10, 2026 · 2:58 PM EDT
Reported Financials

Polaryx Therapeutics Quarterly Growth Metrics

Periods 5 quarters
Latest Jun 2026

Polaryx Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 5 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y) 3.38%
Assets (QoQ) -32.26%237.29%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 11.30%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -40.11%274.74%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -196.19%-49.49%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -25.67%36.57%
EBIT Growth (1y) 61.24%-56.11%
EBIT (QoQ) 82.50%29.52%
EBT Growth (1y) 61.24%-56.11%
EBT (QoQ) 82.50%29.52%
EPS (Basic) Growth (1y) 52.72%-26.67%
EPS (Basic) (QoQ) 80.20%46.94%
EPS (Diluted) Growth (1y) 52.72%-26.67%
EPS (Diluted) (QoQ) 80.20%46.94%
Free Cash Flow Growth (1y)FCF Growth (1y) -196.19%-49.49%
Free Cash Flow (QoQ)FCF (QoQ) -25.67%36.57%
Net Cash Flow Growth (1y)NCF Growth (1y) -357.52%-49.49%
Net Cash Flow (QoQ)NCF (QoQ) -94.12%36.57%
Net Income Growth (1y) 61.24%-56.11%
Net Income (QoQ) 82.50%29.52%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) 49.64%-36.90%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) 80.05%45.75%
Operating Income Growth (1y)Op. Inc Growth (1y) 61.24%-56.11%
Operating Income (QoQ)Op. Inc (QoQ) 82.50%29.52%
Profit After Tax Growth (1y)PAT Growth (1y) 50.12%-38.89%
Profit After Tax (QoQ)PAT (QoQ) 80.24%44.97%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 56.75%70.75%6,937.04%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 66.67%-97.57%81.55%0.00%